PHARMACIES are being urged to adopt a new "Software-as-a-Service" (SaaS) platform allowing remote monitoring of patient vital statistics, as a new revenue-generating model for the sector.
Propell Health has been announced as the Australian partner for the iHealth Remote Monitoring Solution, which uses digitally-connected blood pressure monitors and pulse oximeters.
The system allows pharmacists to view alerts when customers' blood pressure and oxygen saturation levels are outside pre-determined thresholds, and with pricing based on a "per patient per month" model, gives pharmacies a new professional service focusing on chronic disease patients.
"The value of home monitoring and telehealth is reducing hospital admissions, and enabling the customer to have an active role in the management of their disease by tracking their blood pressure, oxygen levels, weight and blood glucose levels," said Propell CEO Craig Simmonds.
Remote monitoring is already in place in several Australian Local Health Districts, Primary Health Networks and aged care organisations nationwide, he said.
Data from iHealth devices can also be integrated into other applications, while SaaS pricing for the system makes the offer "highly attractive" - propellhealth.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 19
